Page 538 - Read Online

Schulze et al. J Cancer Metastasis Treat 2020;6:42 I http://dx.doi.org/10.20517/2394-4722.2020.79 Page 9 of 10

37. Wang J, Lv B, Su Y, Wang X, Bu J, Yao L. Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin resistance in gastric cancer
cells by regulating HMGA1/miR-218 Axis. Onco Targets Ther 2019;12:11325-38.
38. Pan L, Liang W, Fu M, et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer
Res Clin Oncol 2017;143:991-1004.
39. Zhang R, Xia Y, Wang Z, et al. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem Biophys Res Commun 2017;490:406-14.
40. Kogure T, Yan IK, Lin WL, Patel T. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of
intercellular signaling in human hepatocellular cancer. Genes Cancer 2013;4:261-72.
41. Kang M, Ren M, Li Y, Fu Y, Deng M, Li C. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal
squamous cell carcinoma via functioning as a competing endogenous RNA. J Exp Clin Cancer Res 2018;37:171.
42. Yang YN, Zhang R, Du JW, et al. Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer. Cancer Cell Int
2018;18:164.
43. Xu CG, Yang MF, Ren YQ, Wu CH, Wang LQ. Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance
in breast cancer cells. Eur Rev Med Pharmacol Sci 2016;20:4362-8.
44. Li Z, Jiang P, Li J, et al. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal
adenocarcinoma. Oncogene 2018;37:3822-38.
45. Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates
chemosensitivity in human hepatocellular cancer. FEBS Open Bio 2014;4:458-67.
46. Han M, Gu Y, Lu P, et al. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and
activating ERBB2 translation. Mol Cancer 2020;19:26.
47. Qu L, Ding J, Chen C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing
endogenous RNA. Cancer Cell 2016;29:653-68.
48. Dong H, Wang W, Chen R, et al. Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast
cancer. Int J Oncol 2018;53:1013-26.
49. Yang X, Wang L, Li R, et al. The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a
competing endogenous RNA that associates with EZH2. Biochem Biophys Res Commun 2018;502:262-8.
50. Zhang Z, Yin J, Lu C, Wei Y, Zeng A, You Y. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to
temozolomide in glioblastoma. J Exp Clin Cancer Res 2019;38:166.
51. Wang X, Pei X, Guo G, et al. Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer. J
Cell Physiol 2020;235:6896-904.
52. Zhang W, Cai X, Yu J, Lu X, Qian Q, Qian W. Exosome-mediated transfer of lncRNA RP11838N2.4 promotes erlotinib resistance in non-
small cell lung cancer. Int J Oncol 2018;53:527-38.
53. Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol
2015;17:816-26.
54. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived
microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 2009;106:3794-9.
55. Rong L, Li R, Li S, Luo R. Immunosuppression of breast cancer cells mediated by transforming growth factor-beta in exosomes from
cancer cells. Oncol Lett 2016;11:500-4.
56. Keklikoglou I, Cianciaruso C, Güç E, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell
Biol 2019;21:190-202.
57. Paolillo M, Schinelli S. Integrins and exosomes, a dangerous liaison in cancer progression. Cancers (Basel) 2017;9:95.
58. Yue S, Mu W, Erb U, Zöller M. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer
initiating cells and their surrounding. Oncotarget 2015;6:2366-84.
59. Ashiru O, Boutet P, Fernández-Messina L, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand
MICA*008 that is shed by tumor cells in exosomes. Cancer Res 2010;70:481-9.
60. Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp
Med 2002;195:1303-16.
61. Rodrigues G, Hoshino A, Kenific CM, et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat
Cell Biol 2019;21:1403-12.
62. Choi SH, Bylykbashi E, Chatila ZK, et al. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s
mouse model. Science 2018;361:eaan8821.
63. Fan Y, Che X, Qu J, et al. Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis. Ann Surg
Oncol 2019;26:3745-55.
64. Kim DH, Kim H, Choi YJ, et al. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Exp
Mol Med 2019;51:1-13.
65. Yang Y, Li CW, Chan LC, et al. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and
promote tumor growth. Cell Res 2018;28:862-4.
66. Liu H, Chen L, Peng Y, et al. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy. Oncotarget 2018;9:2887-94.
67. Gilligan KE, Dwyer RM. Engineering exosomes for cancer therapy. Int J Mol Sci 2017;18:1122.
68. Gomari H, Forouzandeh Moghadam M, Soleimani M. Targeted cancer therapy using engineered exosome as a natural drug delivery